Abbott Laboratories
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceutic…
What to know about ABT
Abbott Laboratories is a large Healthcare company with a mixed financial profile. It scores well on size and sentiment, but growth is worth keeping an eye on.
Should you consider ABT?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Abbott Laboratories is a large-cap Healthcare company with a mixed overall financial profile — it sits in the upper half of Healthcare stocks (20 of 59).
-
Profitability is roughly average for the S&P 500 — not a standout in either direction.
-
Valuation is in the middle of the pack — neither obviously cheap nor stretched.
-
Growth has been slower than most peers. That's not necessarily a dealbreaker, but it means the investment case rests more on current earnings than future expansion.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
Risk is relatively low — the stock tends to be less volatile than the broader market, which typically means a smoother ride during uncertain periods.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how ABT compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 24.76 | Above avg |
| Forward P/E | 14.59 | Above avg |
| PEG Ratio | 1.34 | Above avg |
| Price to Sales | 3.41 | Average |
| Price to Book | 2.96 | Above avg |
| EV/EBITDA | 15.78 | Average |
| Earnings Yield | 4.04% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 56.50% | Above avg |
| Operating Margin | 13.47% | Average |
| Net Profit Margin | 13.90% | Above avg |
| Return on Equity | 12.33% | Average |
| Return on Invested Capital | 5.59% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 7.80% | Average |
| Revenue Growth (3Y CAGR) | 0.51% | Below avg |
| EPS Growth (YoY) | -19.70% | Below avg |
| Free Cash Flow Growth | 16.44% | Above avg |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 1.39 | Above avg |
| Debt to Equity | 0.65 | Above avg |
| Interest Coverage | 18.17 | Top 25% |
| Altman Z-Score | 4.51 | Above avg |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | — | N/A |
| Dividend Growth (5Y) | -6.89% | Above avg |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 4.79% | Above avg |
| OCF to Sales | 20.97% | Average |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.62 | Above avg |
| Volatility (30-Day) | 27.86% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 1.41% | Top 25% |
| Avg. Analyst Rating | 1.67 | Top 25% |
| Target Upside % | 31.82% | Top 25% |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 153.99B | Top 25% |
How does ABT compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to ABT — based on their financial profile.